Cargando…
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry
BACKGROUND: To this day, there is no data concerning guideline adherence on P2Y12-inhibitors in Austria. Prasugrel and ticagrelor have been shown to be superior to clopidogrel in the treatment of acute coronary syndromes (ACS). However, recent data from European registries showed a reluctant prescri...
Autores principales: | Tscharre, Maximilian, Egger, Florian, Machata, Matthias, Rohla, Miklos, Michael, Nadia, Neumayr, Manuel, Zweiker, Robert, Hajos, Johannes, Adlbrecht, Christopher, Suppan, Markus, Helmreich, Wolfgang, Eber, Bernd, Huber, Kurt, Weiss, Thomas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478120/ https://www.ncbi.nlm.nih.gov/pubmed/28632784 http://dx.doi.org/10.1371/journal.pone.0179349 |
Ejemplares similares
-
Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA): A cluster-randomized trial
por: Rohla, Miklos, et al.
Publicado: (2018) -
Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022) -
Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016) -
Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017) -
Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
por: Rohla, Miklos, et al.
Publicado: (2016)